CELC logo

CELC
Celcuity Inc

1,859
Mkt Cap
$4.8B
Volume
375,865.00
52W High
$112.64
52W Low
$7.58
PE Ratio
-28.27
CELC Fundamentals
Price
$104.39
Prev Close
$103.80
Open
$103.24
50D MA
$92.48
Beta
1.00
Avg. Volume
872,407.59
EPS (Annual)
-$2.83
P/B
38.40
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase?
CELC shares surge as NDA filing and strong phase III data boost optimism around gedatolisib's potential.
Zacks·4h ago
News Placeholder
More News
News Placeholder
Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Celcuity, Inc. (NASDAQ:CELC - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten ratings firms that are presently covering the firm, MarketBeat reports. One...
MarketBeat·7d ago
News Placeholder
Top Biotech Stocks To Add to Your Watchlist - December 20th
Amicus Therapeutics, Vertex Pharmaceuticals, Danaher, United Therapeutics, Moderna, Cidara Therapeutics, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock...
MarketBeat·17d ago
News Placeholder
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026
MindMed and four other biotech disruptors face pivotal studies and FDA decisions in 2026, setting up high-risk, high-reward opportunities for bold investors
Zacks·21d ago
News Placeholder
Top Biotech Stocks To Add to Your Watchlist - December 12th
Danaher, Vertex Pharmaceuticals, United Therapeutics, Moderna, Abivax, argenex, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...
MarketBeat·24d ago
News Placeholder
Celcuity (NASDAQ:CELC) Hits New 1-Year High - Should You Buy?
Celcuity (NASDAQ:CELC) Hits New 1-Year High - Should You Buy...
MarketBeat·24d ago
News Placeholder
Eventide Asset Management LLC Buys 123,774 Shares of Celcuity, Inc. $CELC
Eventide Asset Management LLC increased its position in Celcuity, Inc. (NASDAQ:CELC - Free Report) by 9.8% during the second quarter, according to the company in its most recent filing with the...
MarketBeat·24d ago
News Placeholder
Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank
Adding to the unusually strong performance of the Russell 2000 this year, these top performers may certainly serve as stocks to add to your watchlist
Zacks·26d ago
News Placeholder
Insider Selling: Celcuity (NASDAQ:CELC) Director Sells 3,000 Shares of Stock
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) Director Richard Buller sold 3,000 shares of the firm's stock in a transaction that occurred on Friday, December 5th. The stock was sold at an average...
MarketBeat·27d ago
News Placeholder
Richard Buller Sells 3,000 Shares of Celcuity (NASDAQ:CELC) Stock
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) Director Richard Buller sold 3,000 shares of the company's stock in a transaction on Friday, December 5th. The stock was sold at an average price of...
MarketBeat·28d ago
<
1
2
...
>

Latest CELC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.